Award
NIH Reporter #11311406
Improving Human Hematopoietic Progenitor Cell Cryopreservation using Anti-aging, Nature-inspired and Stress Modulation Formulations
Recipient
CELL PRESERVATION SERVICES, INC.
Award Amount
$314,400.00
Ceiling
$314,400.00
Awarded
September 16, 2026
Identifier
11311406
Award for developing non-toxic cryoprotective agents to improve hematopoietic stem cell preservation, replacing DMSO and enhancing cell viability, under the SBIR program.
Description
The project focuses on developing non-toxic cryoprotective agents for hematopoietic stem cells, aiming to replace DMSO and improve post-thaw cell viability and function. It includes formulation of a cryococktail (Chillout-HC) and a CP dilution reagent (RevitalICE-HC), with a focus on reducing toxicity and addressing cellular aging effects. The project is part of the SBIR program and aims to create a commercially viable, FDA-acceptable cryopreservation solution. It involves in vivo studies and aims to eliminate DMSO toxicity in stem cell cryopreservation.